1.Inefficacy of neck cooling in suppressing core body temperature elevation during exercise in a hot environment: a randomized cross-over trial.
Kotaro ISHIZUKA ; Chikage NAGANO ; Mai TOGAWA ; Kentaro KADO ; Keiichi TAJIMA ; Kimiyo MORI ; Seichi HORIE
Environmental Health and Preventive Medicine 2025;30():60-60
BACKGROUND:
Neck cooling is a practical method for preventing heat-related illness, however, its effectiveness in general workers is not well established. This study aimed to assess the effects of neck cooling on core body temperature and other physiological markers during exercise in a hot environment.
METHODS:
This randomized crossover trial was conducted from November 2023 to April 2024 at the Shared-Use Research Center at UOEH. Fourteen healthy adult males participated in the study under two conditions: with neck cooling (COOL) and without neck cooling (CON). All participants completed both conditions, and the order of condition assignment was determined by a random draw. Participants first rested for 10 minutes in a 28.0 °C, 50% relative humidity environment, followed by a rest in a 35.0 °C, 50% relative humidity environment for another 10 minutes. In the COOL condition, participants wore a neck cooler containing 1,200 g of ice while exercising at 50% Heart Rate Reserve on a bicycle ergometer for 20 minutes. Afterward, they rested for 15 minutes in the hot environment while still wearing the cooler.
MAIN OUTCOME MEASURES:
Core body temperature (rectal and esophageal), forehead skin temperature, and heart rate were continuously monitored and compared using a mixed model. Estimated sweat volume was calculated based on changes in body weight before and after the experiment.
RESULTS:
At the end of the rest period, no significant differences were observed between the COOL and CON conditions in rectal temperature (37.76 ± 0.18 °C versus 37.75 ± 0.24 °C, p = 0.9493), esophageal temperature (37.75 ± 0.30 °C versus 37.76 ± 0.23 °C, p = 0.7325), forehead skin temperature (36.87 ± 0.29 °C versus 36.88 ± 0.27 °C, p = 0.2160), or heart rate (104.18 ± 7.56 bpm versus 107.52 ± 7.40 bpm, p = 0.1035). Estimated sweat loss was similar between conditions (578 ± 175 g for CON versus 572 ± 242 g for COOL, p = 0.5066). While more participants felt cooler in the COOL condition, RPE showed no significant difference.
CONCLUSION
Neck cooling did not significantly affect core temperature or perceived exertion. Maintaining close contact with the skin at sufficiently low temperatures or utilizing cooling methods that prevent excessive negative feedback may be necessary to enhance the effectiveness of neck cooling.
Humans
;
Male
;
Cross-Over Studies
;
Exercise/physiology*
;
Adult
;
Neck/physiology*
;
Hot Temperature/adverse effects*
;
Young Adult
;
Body Temperature
;
Heart Rate
;
Skin Temperature
;
Body Temperature Regulation
;
Cold Temperature
2.Left sided sternocleidomastoid interosseous intravascular papillary endothelial hyperplasia: A case report.
Xiaodi XIAO ; Youchen XIA ; Jianying LIU ; Peng FU
Journal of Peking University(Health Sciences) 2025;57(5):1002-1004
Intravascular papillary endothelial hyperplasia (IPEH), also known as Masson tumor, is a rare vascular benign tumor of blood vessels. It may occur in any part of the body, especially the deep dermis and subcutaneous tissue of the head, neck, fingers and trunk. The imaging and histopathology of IPEH are similar to hemangiosarcoma, especially in the case of active vascular endothelial hyperplasia. IPEH is a reactive proliferative lesion of vascular intima. The etiology is still unclear. After some studies showed that IPEH was a benign lesion, few reports on the etiology of it were reported. IPEH is usually limited to the thrombotic vessels or lumens of vascular malformations, usually accompanied by a clear history of trauma. IPEH usually does not cause any symptoms. It looks like a slow-growing lump. Some cases have been reported with pain and swelling. Although IPEH is relatively rare, its accurate diagnosis is crucial because it may be similar to malignant angiogenic lesions in clinical practice. There were few reports of cases related to intravascular papillary endothelial hyperplasia located in the sternocleidomastoid muscle after reviewing the domestic and foreign literature in recent 10 years. This case reports that a young male, who was admitted to the hospital one month after finding a subcutaneous tumor in the left neck. After admittance, relevant preoperative examinations were completed. After multi-disciplinary discussion and elimination of surgical contraindications, a specific surgical plan was formulated. The tumor was removed under local anesthesia on the second day after admission. During the operation, it was found that the tumor was located between the sternocleidomastoid muscle bundles, and it was sent for pathologic examination. Paraffin section pathology was reported after operation. Histological examination showed that the morphology was consistent with vascular endothelial papillary hyperplasia. There were no related surgical complications and recurrence in the 3-month follow-up. The purpose of this paper is to provide clinicians with a certain understanding of this rare disease through the report of this case of IPEH, and to identify it in later clinical work, and at the same time, to avoid confusion with malignant diseases, such as hemangiosarcoma, leading to unnecessary treatment and increase the cost of treatment.
Humans
;
Male
;
Endothelium, Vascular/pathology*
;
Hemangioendothelioma/surgery*
;
Hyperplasia/pathology*
;
Neck Muscles/surgery*
;
Vascular Neoplasms/pathology*
3.Effect of morphine pump in prepontine cistern via lumbar approach for intractable head and neck cancer pain.
Wenjie ZHANG ; Bohua YIN ; Xinning LI ; Jiaxin LEI ; Yanying XIAO ; Yaping WANG ; Dingquan ZOU
Journal of Central South University(Medical Sciences) 2025;50(6):995-1001
OBJECTIVES:
Managing patients with refractory head and neck cancer pain is one of the more challenging issues in clinical practice, and traditional intrathecal drug delivery also fails to provide adequate analgesia. There are currently no comprehensive and effective treatment methods. This study aims to observe the efficacy and safety of treating intractable head and neck cancer pain with morphine pump via lumbar approach to the prepontine cistern.
METHODS:
A total of 18 patients with intractable head and neck cancer pain treated with prepontine cistern morphine pumps were selected from the Department of Pain Management, Second Xiangya Hospital, Central South University between September 2019 and July 2023. Statistical analysis was performed on patients' preoperative and postoperative (1 week, 1 month, and 2 months after surgery), Numerical Rating Scale (NRS) scores, Self-Rating Depression Scale (SDS) scores, daily oral morphine consumption, the number of daily breakthrough pain episodes, and postoperative daily intrathecal morphine dosage.
RESULTS:
The NRS scores, SDS scores, daily oral morphine consumption, and the number of daily breakthrough pain episodes of patients at each time point after surgery were significantly lower than before surgery (all P<0.05). With the gradual increase in the dosage of intrathecal morphine, the daily oral morphine consumption of patients at each postoperative time point was significantly reduced compared to preoperative levels (all P<0.05). The complications related to the operation were mild, including nausea in 5 cases (31.3%), headache in 2 cases (12.5%); hypotension, urine retention, hypersomnia and constipation in 1 case (6.3% each), and no serious adverse events occurred. All improved and were discharged after symptomatic treatment.
CONCLUSIONS
The implantation of prepontine cistern morphine pump effectively controls intractable head and neck cancer pain, demonstrating characteristics of minimal invasiveness, mild side effects, and low medication dosage under the premise of standardized procedures.
Humans
;
Morphine/administration & dosage*
;
Male
;
Female
;
Middle Aged
;
Head and Neck Neoplasms/surgery*
;
Analgesics, Opioid/administration & dosage*
;
Cancer Pain/drug therapy*
;
Pain, Intractable/etiology*
;
Aged
;
Adult
;
Infusion Pumps, Implantable
;
Pain Management/methods*
4.Factors influencing severity variability in obstructive sleep apnea and the role of fluid shift.
Hongguang LI ; Bowen ZHANG ; Jianhong LIAO ; Yunhan SHI ; Yanru LI
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(1):42-46
Objective:The variability of the apnea-hypopnea index(AHI) measured in the first and second halves of the night is significant in patients with obstructive sleep apnea hypopnea syndrome(OSAHS). This variation may be related to fluid redistribution caused by the supine position during sleep. Methods:Eighty-nine adult subjects were enrolled. Circumferences(neck, chest, waist, and calf) were measured before sleep onset and upon awakening. Polysomnography(PSG) was performed, and the night was divided into two halves based on the midpoint of total sleep time to calculate AHI for each half. The correlation between changes in AHI and changes in circumferences was analyzed. Results:Twenty simple snorers and sixty-nine OSAHS patients were included, with a median AHI of 22.6(11.8, 47.3) events/hour. Compared to pre-sleep measurements, there was no significant change in neck circumference upon awakening in the control group(P=0.073), while reductions were observed in the other three measurements(P=0.006, P=0.038, P<0.001). In the OSAHS group, neck circumference increased(P<0.001), and reductions were noted in the other three measurements(P<0.001 for all), with the most significant change observed in calf circumference 40.0(37.1, 42.0) cm to 38.0(35.8, 40.5) cm. Compared to the first half of the night, total AHI, supine AHI, and NREM AHI significantly decreased in the second half(P=0.010, P=0.031, P=0.001), while no significant changes were observed in lateral AHI and REM AHI(P=0.988, P=0.530). Further analysis revealed a significant relationship between increased chest circumference and decreases in NREM AHI, supine AHI, and supine NREM AHI(P=0.036, P=0.072, P=0.034), as well as between decreased lateral position AHI and increased waist circumference(P=0.048). Additionally, this study found a negative correlation between changes in calf circumference and changes in AHI(R=-0.24, P=0.048), while neck circumference changes positively correlated with changes in AHI(R=0.26, P=0.03). Conclusion:In OSAHS patients during the second half of sleep compared to before sleeping, chest circumference, waist circumference, and calf circumference decrease while neck circumference increases; total AHI, supine position AHI, and NREM period AHI decrease; increases in chest circumference are associated with decreases in NREM period AHI, supine position AHI, supine position NREM period AHI. There is nocturnal variability in AHI among OSAHS patients that may be associated with fluid shifts during sleep.
Humans
;
Sleep Apnea, Obstructive/physiopathology*
;
Male
;
Female
;
Polysomnography
;
Fluid Shifts/physiology*
;
Adult
;
Middle Aged
;
Neck
;
Severity of Illness Index
;
Sleep/physiology*
;
Snoring/physiopathology*
5.Research progress of liposome drug delivery system in the treatment of head and neck cancer.
Bo LIU ; Yaqin TU ; Nan WU ; Hongjun XIAO
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(1):91-96
Head and neck tumors are one of the major diseases that threaten human health. Targeted chemotherapy is an important treatment for head and neck tumors. However, many anti-cancer drugs are difficult to reach effective concentrations in tumors and can cause damage to normal tissues. Therefore, the efficient delivery of anti-tumor drugs, improvement of their therapeutic effects, and reduction of their adverse effects on the whole body and locally are urgent issues in targeted drug research. Liposomes have been widely studied due to their unique characteristics, including amphiphilicity, biocompatibility, biodegradability, and low toxicity. This article outlines the current applications and prospects of liposome drug delivery systems in different treatment modalities for head and neck tumors in recent years, aiming to provide more options for the treatment of head and neck tumors.
Humans
;
Liposomes
;
Head and Neck Neoplasms/drug therapy*
;
Drug Delivery Systems
;
Antineoplastic Agents/administration & dosage*
6.Research progress of aldehyde dehydrogenase type 2 in head and neck malignant tumors.
Ying LI ; Taowei WU ; Tan CHENG ; Ping HAN
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(3):281-284
Alcohol is a high-risk factor of the head and neck tumor, and acetaldehyde dehydrogenase type 2(ALDH2) is an important alcohol metabolism enzyme in the human body, whose function is to metabolize acetaldehyde into non-toxic acetic acid in the human body. Studies have shown that ALDH2 gene polymorphisms increase the risk of head and neck tumors by affecting enzyme activity to regulate the rate of alcohol metabolism in the body, and high levels of ALDH2 expression are beneficial for enhancing head and neck tumor immunity and improve prognosis. This article aims to review the research progress on the relationship between ALDH2 and the occurrence and treatment of head and neck tumors.
Humans
;
Head and Neck Neoplasms/enzymology*
;
Aldehyde Dehydrogenase, Mitochondrial/genetics*
;
Polymorphism, Genetic
7.Clinical analysis of primary cervical neuroblastoma in children.
Chenling SHEN ; Jiarui CHEN ; Ying WANG ; Xiaoyan LI
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(4):344-350
Objective:To explore the clinical manifestations, diagnosis, treatment, pathological types and prognosis of primary cervical neuroblastoma in children. Methods:The clinical data of 11 children with primary cervical neuroblastoma admitted to the Department of Otolaryngology and Head and Neck Surgery at Shanghai Children's Hospital from April 2015 to April 2022 were retrospectively analyzed. The clinical characteristics, imaging findings, pathological types, treatment methods, and outcomes of these 11 patients were examined in conjunction with a review of the literature. Results:The cohort of 11 neuroblastoma patients ranged in age from 28 days to 88 months (median age: 24 months), including 3 males and 8 females. Among the 11 patients, 4 had tumors located in the carotid sheath area, 4 in the cervical space, and 3 in the parapharyngeal and retropharyngeal spaces. The clinical manifestations primarily included painless cervical masses and laryngeal stridor. There were 3 cases of primary cervical tumors with cervical lymph node metastasis and 1 case with bone marrow metastasis. Pathological findings revealed neuroblastoma in 8 cases and ganglionic neuroblastoma in 3 cases. In this group, 7 patients underwent surgery combined with chemotherapy, 2 patients received surgery combined with chemoradiotherapy, and 2 patients underwent surgery alone. Surgical resection was performed via a cervical approach in 7 cases, while 3 cases were treated using a transoral endoscopic approach. Additionally, one patient underwent a transoral endoscopic approach initially and a cervical approach subsequently. All patients completed their treatment and were followed up regularly, with follow-up durations ranging from 6 to 79 months (median: 34 months). Nine patients achieved complete remission, 2 patients achieved partial remission, and none experienced disease progression. Conclusion:Primary cervical neuroblastoma exhibits a high degree of heterogeneity and presents at a younger age, primarily with cervical masses. Compared to external approaches, endoscopy-assisted transoral resection of parapharyngeal tumors offers advantages such as reduced damage to surrounding tissue and no visible neck scars, providing a new method for clinical treatment. Regular follow-up is essential for children with neuroblastoma, along with the establishment of specific disease management protocols and comprehensive care to improve survival quality.
Humans
;
Female
;
Male
;
Neuroblastoma/surgery*
;
Child, Preschool
;
Infant
;
Retrospective Studies
;
Child
;
Head and Neck Neoplasms/pathology*
;
Prognosis
8.A case report of giant neurofibromatosis of maxillofacial, neck and chest was treated by multidisciplinary cooperation.
Shuzhen CHEN ; Leifeng LIU ; Haitao QIU ; Jun YAO ; Qizhu CHEN ; Mei XU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(4):376-378
Neurofibromatosis Type 1 (NF1) is an autosomal dominant hereditary neurological disorder. One of the typical manifestations of NF1 is neurofibroma, which can develop gradually over time. When the volume exceeds 100 cm², it is referred to as giant neurofibroma, representing a tumor-like proliferation of Schwann cells within the nerve fiber sheath. The Department of Otolaryngology at the Affiliated Hospital of Guangdong Medical University received a rare case involving a patient with giant neurofibromatosis affecting the maxillofacial region, neck, and chest. The patient underwent successful surgical treatment with the collaboration of various medical disciplines.
Humans
;
Head and Neck Neoplasms/surgery*
;
Neck
;
Neurofibromatoses
;
Neurofibromatosis 1/surgery*
;
Thoracic Neoplasms/surgery*
9.Clinical analysis of 49 cases of malignant lymphoma of the head and neck in children.
Yanli QU ; Heng ZHAO ; Xuli MA ; Xia LI ; Jing MA
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(5):476-481
Objective:To analyze the clinical characteristics of malignant lymphoma of the head and neck in children, and to improve the understanding and diagnosis and treatment of this type of disease by otolaryngologists. Methods:Clinical data of 49 children with malignant lymphoma of the head and neck hospitalized in the Department of Otorhinolaryngology, Head and Neck Surgery of Kunming Children's Hospital from 2013-2021 were retrospectively analyzed and statistically analyzed according to gender, age distribution, duration of the disease, site of onset, type of pathology and survival status. Results:A total of 49 cases of malignant lymphoma of the head and neck in children were collected, of which, 39 were male and 10 female. The minimum age was 3 years, the maximum was 14 years and 4 months, the median age of onset was 7 years, and the largest percentage (51.02%) of children was in the school age(6-12 years). The duration of the disease ranged from 5 days to 2 years, with a median of 1 month, and the site of the lesion was located in the neck in the majority of cases, 41(83.67%). The pathologic types of hodgkin lymphoma(HL) were 25 cases(51.02%) and non-hodgkin lymphoma(NHL) were 24 cases(48.98%), and among hodgkin lymphomas, mixed-cell classical hodgkin lymphoma was the most common, with 9 cases(18.37%); among non-hodgkin lymphomas,originated from B-cells in 16 cases (32.65%) and from T-cells in 7 cases (14.29%), with Burkitt's lymphoma being the most numerous of B-cell origin in 13 cases (26.53%), and T-cell lymphoblastoid lymphoma being the most common of T-cell origin in 4 cases (8.16%). The follow-up period was from 22 days to 6 years and 10 months, with 3 cases losing, 43 cases surviving, 3 cases dying, with a survival rate of 93
Humans
;
Male
;
Female
;
Child
;
Head and Neck Neoplasms/therapy*
;
Child, Preschool
;
Retrospective Studies
;
Adolescent
;
Lymphoma/therapy*
;
Survival Rate
;
Hodgkin Disease
;
Prognosis
;
Infant
;
Lymphoma, Non-Hodgkin
10.A case report of malignant paraganglioma with lymph node and liver metastasis in the jugular foramen area.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2025;39(5):486-490
Objective:Paragangliomas (PGLs) are chromaffin cell tumors originating from paraganglia and are classified as neuroendocrine neoplasms.They predominantly occur along the distribution area of the paraganglia, commonly occurring between the ages of 20 and 40, with a slight male predominance.They are most frequently found in the axial regions from the skull base to the pelvic cavity. Paragangliomas in the head and neck region typically lack endocrine functionality and primarily manifest through local mass effects. However, clinical signs and symptoms alone cannot reliably distinguish between metastatic and non-metastatic cases. Clinically apparent metastatic paragangliomas are relatively rare. Herein, we present a case of a paraganglioma located in the region of the jugular foramen with liver, bone, and lymph node metastases, and discuss the treatment and prognosis of head and neck paragangliomas.
Humans
;
Head and Neck Neoplasms/pathology*
;
Jugular Foramina/pathology*
;
Liver Neoplasms/secondary*
;
Lymphatic Metastasis
;
Paraganglioma/pathology*

Result Analysis
Print
Save
E-mail